Forward-looking statements for earnings and other performance data contained herein are based on information currently available to the Company, and all potential risks and uncertainties are taken into account. The Company asks that investors understand that changes in conditions may cause actual performance to significantly differ from these projections.
◆ Sales and operating income increased 17.7 billion yen, or 5% and 1.5 billion yen, or 11% respectively, year on year. Sales and operating income increased 8.6 billion yen, or 2% and 6.5 billion yen, or 81% from the latest forecast for the first half.
-Precision Equipment Business ・Sales volume in the first half year increased from a year earlier. Sales rose 24 billion yen, or 44% and operating income posted 4 billion yen. ・Sales rose 8.9 billion yen, or 13 % and operating income grew from zero to 4 billion yen, respectively from the latest forecast.
-Imaging Products Business ・Sales volume in the first half year decreased from a year earlier in all product groups owing to market shrinkage. Sales and operating income fell 13.8 billion yen, or 5% and 3.3 billion yen, or 12%, respectively. ・Sales stayed at the same level while operating income increased 2.2 billion yen, or 10% from the latest forecast.
-Instruments Business ・Sales rose 4.7 billion yen, or 16% and the deficit shrunk 1.6 billion yen year on year. ・Sales grew 1.2 billion yen, or 4% and the deficit shrunk 1 billion yen from the latest forecast.
◆ Interim cash dividend per share : 8 yen Ordinary income and net income forecasts are upgraded by 4 billion yen and 2 billion yen, respectively from the latest forecasts.
-Precision Equipment Business
Sales and operating income forecasts are downgraded by 15 billion yen and 5 billion yen, respectively due to sales of new semiconductor lithography systems fell by 6 units.
-Imaging Products Business
Based on the first half year result, the forecast for sales remains unchanged and operating income is upgraded by 5 billion yen.
-Instruments Business
Based on the first half year result, operating income forecast is upgraded by 500 million yen.
-Medical Business
The latest forecast is not changed both for sales and operating income.
◆ Planned annual cash dividend per share: 16 yen The full-year operating income forecast is revised upwardly by 5 billion yen due to earning recovery measures such as an improvement in product mix. The full-year forecast for operating income is revised upwardly by 500 million yen due to the steady business performance in the first half year. Quarterly Operating Income by Segment * Amounts in this statement are rounded down to the hundred million. The sum of breakdown values may not match the total.
